METHOD FOR TREATING ISCHEMIC CARDIAC DISEASE, OR MYOCARDIAL INFARCTION AND ITS AFTEREFFECTS, OR CEREBRAL ISCHEMIA INDUCED BY ATHEROSCLEROSIS OR ACUTE DYSFUNCTION OF CEREBRAL CIRCULATION, AND ITS AFTEREFFECTS, OR ATHEROSCLEROSIS-INDUCED ISCHEMIA OF INFERIOR LIMBS

摘要

FIELD: medicine. ^ SUBSTANCE: the present innovation deals with treating diseases associated with affected tissue circulation. It deals with injecting mononuclear cells of donor's umbilical cord blood into the blood. Moreover, the above-mentioned donor's cells have got the set of antigens HLA-A, HLA-B, HLA-DR being distinct against the recipient's set of antigens HLA-A, HLA-B, HLA-DR by not less than four antigens. The quantity of introduced cells ranges 2.5 x 106 up to 10 x 106/kg body weight/d. Injection should be repeated 2-10 times at interval of 10-60 d. The innovation provides substitution of dead and/or recipient's regeneration-impotent cells with the above-mentioned donor's cells and enables to decrease the frequency of immunopathological reactions at decreasing the number of introduced donor's mononuclear cells. ^ EFFECT: higher efficiency of therapy. ^ 2 cl, 8 ex, 1 tbl